View in a different locale / language
Austria
Belgium
Bulgaria
Croatia
Czech Republic
Denmark
Finland
France
Germany
Hungary
Ireland
Italy
Aflatoxins and other mycotoxins pose serious health risks and are strictly regulated under the Cannabis Act and international medical cannabis frameworks. Accurate, sensitive testing is essential to ensure product safety, regulatory compliance and market readiness.
Aflatoxins are a group of carcinogenic mycotoxins produced by certain types of moulds. Aflatoxins can be very dangerous for those with compromised immune systems and thus testing for aflatoxins in cannabis is a required test under the Cannabis Act.
Aflatoxins can be extremely harmful to humans, and it is a Cannabis Act requirement to have a certificate of analysis clean of aflatoxins before product release.
Ochratoxin A is another mycotoxin subgroup also shown to be carcinogenic. Testing for ochratoxin A is required to export cannabis product into other countries that have legalised medical cannabis. We follow the EP <2.8.22> method for oOchratoxin A testing.
Would you like to find out more about our mycotoxins testing solutions, or do you need tailored testing support? Contact us today to get in touch with our experts.